PI3K inhibitors curtail MYC-dependent mutant p53 gain-of-function in head and neck squamous cell carcinoma.

Ganci F, Pulito C, Valsoni S, Sacconi A, Turco C, Vahabi M, Manciocco V, Mazza EMC, Meens J, Karamboulas C, Nichols AC, Covello R, Pellini R, Spriano G, Sanguineti G, Muti P, Bicciato S, Ailles L, Strano S, Fontemaggi G, Blandino G.

Clin Cancer Res. 2020 Jan 22. pii: clincanres.2485.2019. doi: 10.1158/1078-0432.CCR-19-2485. [Epub ahead of print]PMID: 31969334